INTERNATIONAL PATENT: BAYLOR COLLEGE OF MEDICINE FILES APPLICATION FOR "ENHANCING CYTOTOXICITY OF ENGINEERED IMMUNE EFFECTORS THROUGH AN ADDITIONAL SYNAPSE-STABILIZING RECEPTOR"

GENEVA, May 14 -- BAYLOR COLLEGE OF MEDICINE (One Baylor PlazaHouston, Texas 77030) filed a patent application (PCT/US2024/053700) for "ENHANCING CYTOTOXICITY OF ENGINEERED IMMUNE EFFECTORS THROUGH AN ADDITIONAL SYNAPSE-STABILIZING RECEPTOR" on Oct 30, 2024. With publication no. WO/2025/096640, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAMONKIN, Maksim (c/o Baylor College of MedicineOne Baylor PlazaHouston, Texas 77030), TSAI, Chiou-Tsun (c/o Baylor College of MedicineOne Baylor PlazaHouston, Texas 77030)

Abstract:...